Development asset linked to Jade Biosciences in public FDA and regional records.
pharma · IgA Nephropathy · Rhematoid Arthritis · JBIO
Jade Biosciences
Jade Biosciences drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Waltham, USA HQ
2024 Founded
72 Employees
Public company Type
JBIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Founded
- 2024
- Employees
- 72
- Programs
- 4
- Drugs
- 1
- Patents
- 2
Jade Biosciences pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Jade Biosciences drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.